ACKR1
Basic information
Region (hg38): 1:159204875-159206500
Previous symbols: [ "FY", "DARC" ]
Links
Phenotypes
GenCC
Source:
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Blood group, Duffy system | BG | Hematologic | Variants associated with a blood group may be important in specific situations (eg, related to transfusion) | Hematologic | 6386656; 8248172; 7663520; 7669660; 7705836; 8547665; 9886340; 9746760; 9731074; 10073905; 10570183; 20932074 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ACKR1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 12 | 15 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 12 | 3 | 3 |
Variants in ACKR1
This is a list of pathogenic ClinVar variants found in the ACKR1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-159204886-G-A | ACKR1-related disorder | Likely benign (Apr 25, 2019) | ||
1-159204893-T-C | Resistance to Plasmodium vivax infection • DUFFY BLOOD GROUP SYSTEM, FY(a-b-) PHENOTYPE • White blood cell count quantitative trait locus 1 | Pathogenic; association; protective (Dec 11, 2017) | ||
1-159205480-C-T | not specified | Uncertain significance (Oct 12, 2022) | ||
1-159205506-G-A | not specified | Uncertain significance (Dec 20, 2021) | ||
1-159205555-G-A | not specified | Uncertain significance (Jun 16, 2024) | ||
1-159205564-G-A | DUFFY BLOOD GROUP SYSTEM, FYA/FYB POLYMORPHISM • not specified • ACKR1-related disorder | Benign (May 27, 2016) | ||
1-159205585-C-T | not specified | Uncertain significance (Jul 06, 2021) | ||
1-159205638-C-T | Duffy Blood group system | Affects (Jul 01, 2021) | ||
1-159205684-T-G | not specified | Uncertain significance (Jun 28, 2023) | ||
1-159205703-C-A | not specified | Uncertain significance (Sep 12, 2023) | ||
1-159205704-C-T | DUFFY BLOOD GROUP SYSTEM, FY(bwk) PHENOTYPE | Pathogenic (Jun 01, 2001) | ||
1-159205718-CCCTGGCTGGCCTGT-C | DUFFY BLOOD GROUP SYSTEM, FY(a-b-) PHENOTYPE | Pathogenic (Apr 01, 2000) | ||
1-159205720-C-G | not specified | Uncertain significance (Mar 31, 2023) | ||
1-159205737-G-A | ACKR1-related disorder | Benign (Oct 21, 2019) | ||
1-159205753-G-A | not specified | Uncertain significance (Sep 20, 2023) | ||
1-159205795-G-A | not specified | Uncertain significance (Oct 06, 2024) | ||
1-159205805-C-A | not specified | Uncertain significance (Dec 04, 2024) | ||
1-159205810-G-A | not specified | Likely benign (Jan 27, 2022) | ||
1-159205921-A-G | not specified | Uncertain significance (Oct 23, 2024) | ||
1-159205974-C-G | not specified | Uncertain significance (Dec 03, 2024) | ||
1-159206042-G-A | ACKR1-related disorder | Likely benign (Sep 17, 2019) | ||
1-159206094-G-A | not specified | Uncertain significance (Nov 08, 2022) | ||
1-159206153-G-A | Benign (Jul 31, 2018) | |||
1-159206168-G-A | not specified | Uncertain significance (Sep 07, 2022) | ||
1-159206170-A-G | not specified | Uncertain significance (Aug 14, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ACKR1 | protein_coding | protein_coding | ENST00000368121 | 1 | 3194 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000214 | 0.516 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.489 | 193 | 175 | 1.10 | 0.00000855 | 2122 |
Missense in Polyphen | 62 | 59.501 | 1.042 | 779 | ||
Synonymous | -0.338 | 87 | 83.1 | 1.05 | 0.00000412 | 799 |
Loss of Function | 0.411 | 6 | 7.19 | 0.835 | 3.11e-7 | 80 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Atypical chemokine receptor that controls chemokine levels and localization via high-affinity chemokine binding that is uncoupled from classic ligand-driven signal transduction cascades, resulting instead in chemokine sequestration, degradation, or transcytosis. Also known as interceptor (internalizing receptor) or chemokine-scavenging receptor or chemokine decoy receptor. Has a promiscuous chemokine-binding profile, interacting with inflammatory chemokines of both the CXC and the CC subfamilies but not with homeostatic chemokines. Acts as a receptor for chemokines including CCL2, CCL5, CCL7, CCL11, CCL13, CCL14, CCL17, CXCL5, CXCL6, IL8/CXCL8, CXCL11, GRO, RANTES, MCP-1, TARC and also for the malaria parasites P.vivax and P.knowlesi. May regulate chemokine bioavailability and, consequently, leukocyte recruitment through two distinct mechanisms: when expressed in endothelial cells, it sustains the abluminal to luminal transcytosis of tissue-derived chemokines and their subsequent presentation to circulating leukocytes; when expressed in erythrocytes, serves as blood reservoir of cognate chemokines but also as a chemokine sink, buffering potential surges in plasma chemokine levels.;
- Pathway
- Malaria - Homo sapiens (human);GPCRs, Other;Peptide GPCRs;Signaling by GPCR;Signal Transduction;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding
(Consensus)
Recessive Scores
- pRec
- 0.0721
Intolerance Scores
- loftool
- rvis_EVS
- 0.28
- rvis_percentile_EVS
- 71.41
Haploinsufficiency Scores
- pHI
- 0.0602
- hipred
- N
- hipred_score
- 0.153
- ghis
- 0.448
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Ackr1
- Phenotype
- homeostasis/metabolism phenotype; immune system phenotype; skeleton phenotype;
Gene ontology
- Biological process
- defense response;inflammatory response;G protein-coupled receptor signaling pathway;regulation of chemokine production;chemokine-mediated signaling pathway
- Cellular component
- early endosome;plasma membrane;integral component of membrane;recycling endosome
- Molecular function
- transmembrane signaling receptor activity;G protein-coupled receptor activity;C-C chemokine binding;signaling receptor activity